Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Meng, Xiang-Feia | Yu, Jin-Taia; b; c; * | Wang, Hui-Fub | Tan, Meng-Shanc | Wang, Chonga | Tan, Chen-Chena | Tan, Lana; b; c; *
Affiliations: [a] Department of Neurology, Qingdao Municipal Hospital, School of Medicine, Qingdao University, China | [b] Department of Neurology, Qingdao Municipal Hospital, Nanjing Medical University, China | [c] Department of Neurology, Qingdao Municipal Hospital, College of Medicine and Pharmaceutics, Ocean University of China, China
Correspondence: [*] Correspondence to: Lan Tan and Jin-Tai Yu, Department of Neurology, Qingdao Municipal Hospital, School of Medicine, Qingdao University, No. 5 Donghai Middle Road, Qingdao, Shandong Province 266071, PR China. Tel.: +86 532 8890 5659; Fax: +86 532 85968434; E-mails: dr.tanlan@163.com (Lan Tan); yu-jintai@163.com (Jin-Tai Yu).
Abstract: Background/Objective:We examine whether midlife vascular risk factors (VRFs) are associated with increased risk of incident Alzheimer’s disease (AD) in a systematic review and meta-analysis of published cohort studies. Methods:Original cohort studies were included if they reported adjusted combined odds ratio (COR) and corresponding 95% confidence intervals (CIs) or enough information to quantify the association between risk for AD in late-life and baseline VRFs of midlife. Results:There were positive and significant associations between high blood pressure (COR 1.31; 95% CI: 1.01–1.70), hypercholesterolemia (COR 1.72; 95% CI: 1.32–2.24), obesity (COR 1.88; 95% CI: 1.32–2.69), and diabetes mellitus in midlife (COR 1.4; 95% CI: 1.25–1.57). Smoking and hyperhomocysteinemia (although only one high-quality paper) were also associated with an increased risk of AD generally. Conclusions:These results strengthen the epidemiological evidence that VRFs of midlife significantly increase risk for AD.
Keywords: Alzheimer's disease, diabetes mellitus, high blood pressure, hypercholesterolemia, hyperhomocysteinemia, meta-analysis, midlife vascular risk factors, obesity, smoking, systematic review
DOI: 10.3233/JAD-140954
Journal: Journal of Alzheimer's Disease, vol. 42, no. 4, pp. 1295-1310, 2014
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl